Development of Therapeutic Products for Antibiotic Resistant Bacteria

NIH RePORTER · NIH · N01 · $7,440,148 · view on reporter.nih.gov ↗

Abstract

To support the advanced development of a promising candidate therapeutics. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.

Key facts

NIH application ID
10630898
Project number
75N93020C00016-P00003-9999-1
Recipient
VENATORX PHARMACEUTICALS, INC.
Principal Investigator
DANIEL PEVEAR
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$7,440,148
Award type
Project period
2020-07-01 → 2023-05-29